NCT05667194View on ClinicalTrials.gov

Phase 1 Trial of KH617

PHASE1RecruitingINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

December 26, 2022

Primary Completion Date

September 30, 2030

Study Completion Date

August 31, 2031

Conditions
Advanced Solid Tumors
Interventions
DRUG

KH617

KH617 is s freeze-dried powder injection

Trial Locations (1)

100000

RECRUITING

Beijing Titan Hospital,Capital Medical University, Beijing

All Listed Sponsors
lead

Sichuan Honghe Biotechnology Co., Ltd.

INDUSTRY